Caxton Associates (UK)’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.7M Buy
+38,738
New +$1.77M 0.04% 256
2025
Q4
Sell
-13,471
Closed -$569K 917
2025
Q3
$569K Sell
13,471
-44,682
-77% -$1.8M 0.01% 433
2025
Q2
$2.13M Buy
58,153
+1,561
+3% +$58K 0.05% 177
2025
Q1
$2.16M Buy
+56,592
New +$2.11M 0.08% 143

Other funds holding OHI

Caxton Associates (UK)'s OHI Position: Q1 2026 in Review

Caxton Associates (UK) opened a new position in Omega Healthcare (OHI) in Q1 2026: 38,738 shares worth $1.7M. The stake represents 0.04% of the portfolio and ranks #256 among its holdings. This is a return to the name: Caxton Associates (UK) previously reported a position in OHI as recently as Q3 2025.

Caxton Associates (UK) first reported a position in OHI in Q1 2025 and has held it in 4 quarters since. The position peaked at $2.16M in Q1 2025. 740 funds tracked by Wall St. Rank hold OHI as of Q1 2026.

  • Caxton Associates (UK) held 38,738 shares of Omega Healthcare worth $1.7M as of Q1 2026.
  • Omega Healthcare was a new Caxton Associates (UK) position in Q1 2026.
  • Omega Healthcare made up 0.04% of Caxton Associates (UK)'s portfolio in Q1 2026, its #256 holding.
  • Caxton Associates (UK) first reported a position in Omega Healthcare in Q1 2025 and has held it in 4 quarters since.
  • Caxton Associates (UK)'s Omega Healthcare position peaked at $2.16M in Q1 2025.
  • 740 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.